Tnxp stock price forecast recent institutional accumulation has

Recent institutional accumulation has slightly improved the TNXP stock price forecast, suggesting cautious optimism among long‑term growth funds. Terms and Privacy Policy Your Privacy Choices CA Privacy Notice More Info Tonix Pharmaceuticals (TNXP) has announced a 1-for-100 reverse stock split effective February 5, 2025. This corporate action aims to meet NASDAQ's $1.00 minimum bid price requirement for continued listing. The company will maintain its 'TNXP' trading symbol under a new CUSIP number (890260839). The TNXP stock price forecast incorporates elevated volatility indexes, hinting that swing traders could find opportunities during key news windows.